Liquid Biopsy Market: Global Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2017-2021 and Forecast 2022-2028

$ PRICE - $ 3,000.00$ 8,900.00

Liquid Biopsy Market: Product Type (Consumables, Instruments) Application Type (Blood, Urine Others) Sample Type (Lung Cancer, Breast Cancer, Colorectal Cancer, Prostate Cancer, Liver Cancer Others) End User (Hospitals, Diagnostic Laboratories, Academic and Research Centers Others) and Geography

 

 

$ PRICE - $ 3,000.00$ 8,900.00
Clear selection
Clear
$ PRICE - $ 3,000.00$ 8,900.00
FacebookTwitterLinkedinEmail
SKU: N/A Category:

Report

Description

Liquid Biopsy Market size was valued at USD 4.4 in 2022 and is expected grow at a CAGR of 18.2% from 2022-2028. The market is gaining traction in recent times owing to its accurate, effective results in comparison with traditional cancer screening methods, which are achieved through minimal invasiveness and expenses. Challenges associated with traditional biopsies such as invasiveness, ill-informed results, post-sampling medical challenges and costs are prompting the healthcare professionals to adopt less invasive liquid biopsy tests for cancer screening and management, which is projected to create significant market demand for liquid biopsy products and services over the forecast period. Moreover, several clinical research activities related to biomarkers are in late stage and it is expected that upon successful launch and commercialization of these tests over the forecast period will result in significant market growth. This report studies market dynamics elaborately to identify the current trends & drivers, future opportunities and possible challenges to the key stakeholders operating in the market. In addition, This report includes new product introductions; regulatory scenario and competition analysis with vividly illustrated the competition dashboard to assess the market competition. Moreover, PBI analyzed liquid biopsy market to better equip clients with possible investment opportunities across the regions (Regional Investment Hot-Spots) and market unmet needs (Product Opportunities).

 

 

Liquid Biopsy Market

MARKET SUMMARY
-
18.2%
  • Study Period– 2022 – 2028
  • Base Year– 2021
  • CAGR– 18.2%
  • Largest Market– North America
  • Fastest Growing Market–  Asia-Pacific

Liquid Biopsy Market

  • The report on global liquid biopsy market gives historical, current and future market sizes (US$ Mn) based on the basis of product & services type, biomarker type, sample type, application, analysis method, end-user and geographic regions.
  • liquid biopsy market report gives comprehensive outlook across the region with special emphasis on key regions such as North America, Europe, Asia Pacific, Latin America and Middle East and Africa.
  • Key stakeholders of the report include suppliers, manufacturers, marketers, policymakers, and healthcare service providers engaged in manufacturing, supply, and usage of liquid biopsy products and services.
Key Players
  • Biocept
  • Bio-Rad Laboratories
  • Fraunhofer-Gesellschaft
  • Guardant Health
  • Janssen Diagnostics, LLC
Liquid Biopsy Market

Drivers And Restraints

Players in the global liquid biopsy market increasingly attracting the investments in recent times for development and commercialization of late-stage products through IPOs. For instance, RainDance Technologies and Biocept filled IPOs in 2015 and 2014 respectively to develop advanced liquid biopsy technologies to aid physicians to devise suitable treatment strategies. Moreover, growing awareness among key stakeholders regarding liquid biopsy assays expected to drive market demand for these tests over the forecast period across the globe.


North-America got significant share

Liquid Biopsy Market

North America market expected to hold the higher revenue share in global liquid biopsy market and projected to remain same over the forecast period owing to accessibility, availability of advanced diagnostic tools such as liquid biopsy in the region. Asia-pacific liquid biopsy market projected to grow at significant CAGR over the forecast period in comparison with other regions owing to large medical unmet need in the region.

Latin America
Latin-America
North-America
North-America
Europe
Europe
Asia Pacific
Asia-Pacific
Middle East
Middle East

Key

Features of the Report

  • The report provides granular level information about the market size, regional market share, historic market (2017 – 2022) and forecast (2023 – 2029)
  • The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and their key strategies
  • The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
  • The report tracks recent innovations, key developments and startup’s details that are actively working in the market
  • The report provides plethora of information about market entry strategies, regulatory framework and reimbursement scenario
  • The report analyses the impact of socio-political environment through PESTLE Analysis and competition through Porter’s Five Force Analysis in addition to recent technology advancements and innovations in the market
Liquid Biopsy Market Segmentation


Location

GEOGRAPHY

Frequently Asked Questions

2021 is the base year and 2028 is the forecast year.

The report covers the five regions and 15+ countries market data: North America (United States, Canada), Europe (Germany, France, Italy, Spain, and United Kingdom (UK), Asia Pacific (China, India, Japan, Australia & New Zealand), Latin America (Brazil, Mexico, Argentina) and Middle East and Africa (Saudi Arabia, United Arab Emirates, South Africa).

In our report, we provide 12-15 market players’ information into the report. However, based on the client’s request we will provide additional country and regional market players information as well.


Report

Table Of Content

1. Executive summary
2. Global Liquid Biopsy Market Introduction
2.1. Global Liquid Biopsy Market – Taxonomy
2.2. Global Liquid Biopsy Market –Definitions
2.2.1. By Product Type
2.2.2. By Application Type
2.2.3. By Sample Type
2.2.4. By End User
3. Global Liquid Biopsy Market Dynamics
3.1. Drivers
3.2. Restraints
3.3. Opportunities/Unmet Needs of the Market
3.4. Trends
3.5. Global Liquid Biopsy Market Dynamics – Factors Impact Analysis
3.6. Global Liquid Biopsy Market – Regulations
3.6.1. U.S.
3.6.2. Europe
3.7. Federal Grants for Liquid Biopsy Startups
3.8. Venture Capital Investments in Liquid Biopsy Companies
3.9. Product Innovations
3.10. Startups working in the Liquid Biopsy
3.11. Novel Applications of Liquid Biopsy
4. Global Liquid Biopsy Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028
4.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
4.2. Year-over-Year (Y-o-Y) Growth Analysis (%)
4.3. Market Opportunity Analysis
5. Global Liquid Biopsy Market, By Product Type, 2017 – 2021 and Forecast, 2022 – 2028
5.1. Consumables
5.1.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
5.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.1.3. Market Opportunity Analysis
5.2. Instruments
5.2.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
5.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.2.3. Market Opportunity Analysis
6. Global Liquid Biopsy Market, By Sample Type, 2017 – 2021 and Forecast, 2022 – 2028
6.1. Blood
6.1.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
6.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.1.3. Market Opportunity Analysis
6.2. Urine
6.2.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
6.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.3. Others
6.3.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
6.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7. Global Liquid Biopsy Market Forecast, By Application Type, 2017 – 2021 and Forecast, 2022 – 2028
7.1.  Lung Cancer
7.1.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
7.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.1.3. Market Opportunity Analysis
7.2. Breast Cancer
7.2.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
7.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.2.3. Market Opportunity Analysis
7.3. Colorectal Cancer
7.3.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
7.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.3.3. Market Opportunity Analysis
7.4. Prostate Cancer
7.4.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
7.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.4.3. Market Opportunity Analysis
7.5. Liver Cancer
7.5.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
7.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.5.3. Market Opportunity Analysis
7.6. Others
7.6.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
7.6.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.6.3. Market Opportunity Analysis
8. Global Liquid Biopsy Market Forecast, By End User Type, 2017 – 2021 and Forecast, 2022 – 2028
8.1.  Hospitals
8.1.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
8.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.1.3. Market Opportunity Analysis
8.2. Diagnostic Laboratories
8.2.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
8.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.2.3. Market Opportunity Analysis
8.3. Academic and Research Centers
8.3.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
8.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.3.3. Market Opportunity Analysis
8.4. Others
8.4.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
8.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.4.3. Market Opportunity Analysis
9. Global Liquid Biopsy Market Forecast, By Region, 2017 – 2021 and Forecast, 2022 – 2028
9.1. North America
9.1.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
9.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
9.1.3. Market Opportunity Analysis
9.2. Europe
9.2.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
9.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
9.2.3. Market Opportunity Analysis
9.3. Asia-Pacific
9.3.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
9.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
9.3.3. Market Opportunity Analysis
9.4. Latin America
9.4.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
9.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
9.4.3. Market Opportunity Analysis
9.5. Middle East and Africa
9.5.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
9.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
9.5.3. Market Opportunity Analysis
9.6. Global Liquid Biopsy Market – Opportunity Analysis Index, By Product Type, By Application Type, Sample Type, End User, and Region, 2022 – 2028
10. North America Liquid Biopsy Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028
10.1. By Product Type Analysis (2017 – 2021) and Forecast (2022 – 2028) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
10.1.1. Consumables
10.1.2. Instruments
10.2. By Sample Type Analysis (2017 – 2021) and Forecast (2022 – 2028) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
10.2.1. Blood
10.2.2. Urine
10.2.3. Others
10.3. Application Type Analysis (2017 – 2021) and Forecast (2022 – 2028) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
10.3.1. Lung Cancer
10.3.2. Breast Cancer
10.3.3. Colorectal Cancer
10.3.4. Prostate Cancer
10.3.5. Liver Cancer
10.3.6. Others
10.4. End User Analysis (2017 – 2021) and Forecast (2022 – 2028) by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
10.4.1. Hospitals
10.4.2. Diagnostic Laboratories
10.4.3. Academic and Research Centers
10.4.4. Others
10.5. Country Analysis (2017 – 2021) and Forecast (2022 – 2028) by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
10.5.1. U.S.
10.5.2. Canada
10.6. North America Liquid Biopsy Market – Opportunity Analysis Index, By Product Type, By Application Type, By Sample Type, End User and Country, 2022 – 2028
10.7. North America Liquid Biopsy Market Dynamics – Trends
11. Europe Liquid Biopsy Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028
11.1. By Product Type Analysis (2017 – 2021) and Forecast (2022 – 2028) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
11.1.1. Consumables
11.1.2. Instruments
11.2. By Sample Type Analysis (2017 – 2021) and Forecast (2022 – 2028) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
11.2.1. Blood
11.2.2. Urine
11.2.3. Others
11.3. Application Type Analysis (2017 – 2021) and Forecast (2022 – 2028) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
11.3.1. Lung Cancer
11.3.2. Breast Cancer
11.3.3. Colorectal Cancer
11.3.4. Prostate Cancer
11.3.5. Liver Cancer
11.3.6. Others
11.4. End User Analysis (2017 – 2021) and Forecast (2022 – 2028) by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
11.4.1. Hospitals
11.4.2. Diagnostic Laboratories
11.4.3. Academic and Research Centers
11.4.4. Others
11.5. Country Analysis (2017 – 2021) and Forecast (2022 – 2028) by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
11.5.1. Germany
11.5.2. UK
11.5.3. France
11.5.4. Spain
11.5.5. Italy
11.5.6. Russia
11.5.7. Poland
11.5.8. Holland
11.5.9. Rest of Europe
11.6. Europe Liquid Biopsy Market – Opportunity Analysis Index, Opportunity Analysis Index, By Product Type, By Application Type, By Sample Type, End User and Country, 2022 – 2028
11.7. Europe Liquid Biopsy Market Dynamics – Trends
12. Asia-Pacific Liquid Biopsy Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028
12.1. By Product Type Analysis (2017 – 2021) and Forecast (2022 – 2028) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
12.1.1. Consumables
12.1.2. Instruments
12.2. By Sample Type Analysis (2017 – 2021) and Forecast (2022 – 2028) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
12.2.1. Blood
12.2.2. Urine
12.2.3. Others
12.3. Application Type Analysis (2017 – 2021) and Forecast (2022 – 2028) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
12.3.1. Lung Cancer
12.3.2. Breast Cancer
12.3.3. Colorectal Cancer
12.3.4. Prostate Cancer
12.3.5. Liver Cancer
12.3.6. Others
12.4. End User Analysis (2017 – 2021) and Forecast (2022 – 2028) by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
12.4.1. Hospitals
12.4.2. Diagnostic Laboratories
12.4.3. Academic and Research Centers
12.4.4. Others
12.5. Country Analysis (2017 – 2021) and Forecast (2022 – 2028) by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
12.5.1. Japan
12.5.2. China
12.5.3. India
12.5.4. ASEAN
12.5.5. Australia & New Zealand
12.5.6. Rest of Asia-Pacific
12.6. Asia-Pacific Liquid Biopsy Market – Opportunity Analysis Index, By Product Type, By Application Type, By Sample Type, End User and Country, 2022 – 2028
12.7. Asia-Pacific Liquid Biopsy Market Dynamics – Trends
13. Latin America Liquid Biopsy Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028
13.1. By Product Type Analysis (2017 – 2021) and Forecast (2022 – 2028) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
13.1.1. Consumables
13.1.2. Instruments
13.2. By Sample Type Analysis (2017 – 2021) and Forecast (2022 – 2028) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
13.2.1. Blood
13.2.2. Urine
13.2.3. Others
13.3. Application Type Analysis (2017 – 2021) and Forecast (2022 – 2028) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
13.3.1. Lung Cancer
13.3.2. Breast Cancer
13.3.3. Colorectal Cancer
13.3.4. Prostate Cancer
13.3.5. Liver Cancer
13.3.6. Others
13.4. End User Analysis (2017 – 2021) and Forecast (2022 – 2028) by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
13.4.1. Hospitals
13.4.2. Diagnostic Laboratories
13.4.3. Academic and Research Centers
13.4.4. Others
13.5. Country Analysis (2017 – 2021) and Forecast (2022 – 2028) by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
13.5.1. Brazil
13.5.2. Mexico
13.5.3. Argentina
13.5.4. Venezuela
13.5.5. Rest of Latin America
13.6. Latin America Liquid Biopsy Market – Opportunity Analysis Index, By Product Type, By Application Type, By Sample Type, End User and Country, 2022 – 2028
13.7. Latin America Liquid Biopsy Market Dynamics – Trends
14. Middle East and Africa Liquid Biopsy Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028
14.1. By Product Type Analysis (2017 – 2021) and Forecast (2022 – 2028) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
14.1.1. Consumables
14.1.2. Instruments
14.2. By Sample Type Analysis (2017 – 2021) and Forecast (2022 – 2028) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
14.2.1. Blood
14.2.2. Urine
14.2.3. Others
14.3. Application Type Analysis (2017 – 2021) and Forecast (2022 – 2028) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
14.3.1. Lung Cancer
14.3.2. Breast Cancer
14.3.3. Colorectal Cancer
14.3.4. Prostate Cancer
14.3.5. Liver Cancer
14.3.6. Others
14.4. End User Analysis (2017 – 2021) and Forecast (2022 – 2028) by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
14.4.1. Hospitals
14.4.2. Diagnostic Laboratories
14.4.3. Academic and Research Centers
14.4.4. Others
14.5. Country Analysis (2017 – 2021) and Forecast (2022 – 2028) by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
14.5.1. Gulf Cooperation Council (GCC) Countries
14.5.2. Israel
14.5.3. South Africa
14.5.4. Rest of MEA
14.6. MEA Liquid Biopsy Market – Opportunity Analysis Index, By Product Type, By Application Type, By Sample Type, End User and Country, 2022 – 2028
14.7. MEA Liquid Biopsy Market Dynamics – Trends
15. Competition Landscape
15.1. Strategic Dashboard of Top Market Players
15.2. Company Profiles (Introduction, Financial Analysis, Product & Service Offerings, Key Developments, Strategies, and SWOT Analysis)
15.2.1. Catabasis Pharmaceuticals Inc.
15.2.2. NS Pharma, Inc
15.2.3. Marathon Pharmaceuticals, LLC
15.2.4. ITALFARMACO S.p.A.
15.2.5. FibroGen, Inc.
15.2.6. Summit Therapeutics plc
15.2.7. PTC Therapeutics
15.2.8. Santhera Pharmaceuticals
15.2.9. Sarepta Therapeutics, Inc.
16. Research Methodology
17. Key Assumptions and Acronyms

Report

Company Profile

  • Catabasis Pharmaceuticals Inc.
  • NS Pharma, Inc
  • Marathon Pharmaceuticals, LLC
  • ITALFARMACO S.p.A.
  • FibroGen, Inc.
  • Summit Therapeutics plc
  • PTC Therapeutics
  • Santhera Pharmaceuticals
  • Sarepta Therapeutics, Inc.

Description

Liquid Biopsy Market size was valued at USD 4.4 in 2022 and is expected grow at a CAGR of 18.2% from 2022-2028. The market is gaining traction in recent times owing to its accurate, effective results in comparison with traditional cancer screening methods, which are achieved through minimal invasiveness and expenses. Challenges associated with traditional biopsies such as invasiveness, ill-informed results, post-sampling medical challenges and costs are prompting the healthcare professionals to adopt less invasive liquid biopsy tests for cancer screening and management, which is projected to create significant market demand for liquid biopsy products and services over the forecast period. Moreover, several clinical research activities related to biomarkers are in late stage and it is expected that upon successful launch and commercialization of these tests over the forecast period will result in significant market growth. This report studies market dynamics elaborately to identify the current trends & drivers, future opportunities and possible challenges to the key stakeholders operating in the market. In addition, This report includes new product introductions; regulatory scenario and competition analysis with vividly illustrated the competition dashboard to assess the market competition. Moreover, PBI analyzed liquid biopsy market to better equip clients with possible investment opportunities across the regions (Regional Investment Hot-Spots) and market unmet needs (Product Opportunities).

 

 

ASIA PACIFIC OFFICE

Precision Business Insights, MIG 366, SAI PLAZA, 1st Floor, KPHB Colony, Hyderabad - 500072

EUROPE OFFICE

Precision Business Insights, Kemp House, 152 – 160 City Road, London EC1V 2NX